Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Orlando

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
The Prostate|December 12, 2024
Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-Invisible Prostate Cancers: A Matched-Pair AnalysisMarco Oderda, Alessandro Marquis, Luca Bertero, et al.
Pathologica|April 9, 2026
Analysis of histological parameters of aggressiveness in resected lung squamous cell carcinomaGiorgia Andrea Impalà, Alessandra Pittaro, Francesco Guerrera, et al.
Frontiers in Medicine|July 24, 2024
Prognostic and predictive role of YKL-40 in anal squamous cell carcinoma: a serological and tissue-based analysis in a multicentric cohortAlessandro Gambella, Rebecca Senetta, Enrico Costantino Falco, et al.
Nature Genetics|September 19, 2018
Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancerGiulia Orlando, Philip J Law, Alex J Cornish, et al.
Pharmacological Research|March 6, 2023
First pilot case-control interventional study using autologous extracellular vesicles to treat chronic venous ulcers unresponsive to conventional treatmentsLorenzo Gibello, Sergio D'Antico, Marika Salafia, et al.
Endocrine Pathology|February 18, 2026
From Tissue Architecture To Genetic Signature: Artificial intelligence-based Analysis of Reticulin Framework and Clinical Variables Predicts Molecular Cluster in ParagangliomasEleonora Duregon, Mirko Parasiliti-Caprino, Giulia Orlando, et al.
Nature Communications|November 25, 2016
Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expressionNi Li, David C Johnson, Niels Weinhold, et al.
Breast Cancer Research : BCR|November 4, 2025
IL-3/STAT5/miR-155-5p axis supports stem-related pathway reprogramming in TNBCAlessandro Sarcinella, Sharad Kholia, Saveria Femminò, et al.
Genes|August 26, 2022
Prognostic Analysis of the IDH1 G105G (rs11554137) SNP in IDH-Wildtype GlioblastomaAyoub Saaid, Matteo Monticelli, Alessia Andrea Ricci, et al.
International Journal of Molecular Sciences|October 14, 2022
Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural MesotheliomaIacopo Gesmundo, Francesca Pedrolli, Nicoletta Vitale, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The Prostate|December 12, 2024
Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-Invisible Prostate Cancers: A Matched-Pair AnalysisMarco Oderda, Alessandro Marquis, Luca Bertero, et al.
Pathologica|April 9, 2026
Analysis of histological parameters of aggressiveness in resected lung squamous cell carcinomaGiorgia Andrea Impalà, Alessandra Pittaro, Francesco Guerrera, et al.
Frontiers in Medicine|July 24, 2024
Prognostic and predictive role of YKL-40 in anal squamous cell carcinoma: a serological and tissue-based analysis in a multicentric cohortAlessandro Gambella, Rebecca Senetta, Enrico Costantino Falco, et al.
Nature Genetics|September 19, 2018
Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancerGiulia Orlando, Philip J Law, Alex J Cornish, et al.
Pharmacological Research|March 6, 2023
First pilot case-control interventional study using autologous extracellular vesicles to treat chronic venous ulcers unresponsive to conventional treatmentsLorenzo Gibello, Sergio D'Antico, Marika Salafia, et al.
Endocrine Pathology|February 18, 2026
From Tissue Architecture To Genetic Signature: Artificial intelligence-based Analysis of Reticulin Framework and Clinical Variables Predicts Molecular Cluster in ParagangliomasEleonora Duregon, Mirko Parasiliti-Caprino, Giulia Orlando, et al.
Nature Communications|November 25, 2016
Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expressionNi Li, David C Johnson, Niels Weinhold, et al.
Breast Cancer Research : BCR|November 4, 2025
IL-3/STAT5/miR-155-5p axis supports stem-related pathway reprogramming in TNBCAlessandro Sarcinella, Sharad Kholia, Saveria Femminò, et al.
Genes|August 26, 2022
Prognostic Analysis of the IDH1 G105G (rs11554137) SNP in IDH-Wildtype GlioblastomaAyoub Saaid, Matteo Monticelli, Alessia Andrea Ricci, et al.
International Journal of Molecular Sciences|October 14, 2022
Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural MesotheliomaIacopo Gesmundo, Francesca Pedrolli, Nicoletta Vitale, et al.
Pageof 5